This post may refer to COVID-19
To access official information about the coronavirus, access CDC - Centers for Disease Control and Prevention.
www.cbsnews.com
FDA approves first COVID-19 drug, remdesivir
The antiviral drug reduces recovery time but has not been found to cut the risk of dying from COVID-19.
Health
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
It had been authorized for use on an emergency basis since spring, and now becomes the first drug to win full Food and Drug Administration approval for treating COVID-19. President Donald Trump received it when he was sickened earlier this month.